Restatement - Summary of Significant Effect of Restatement (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								11 Months Ended		12 Months Ended
	Sep. 29, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 30, 2016	Sep. 30, 2016	Jul. 01, 2016	Apr. 01, 2016	Jan. 01, 2016	Oct. 02, 2015		Sep. 29, 2017		Sep. 30, 2016		Oct. 02, 2015
Consolidated Statement of Operations
Net Sales	$ 528,650	$ 504,107	$ 509,131	$ 458,416	$ 544,574	$ 517,091	$ 490,310	$ 441,478	$ 1,774,449	[1]	$ 2,000,304	[1]	$ 1,993,453	[1]	$ 2,002,793	[2]
Cost of Sales	362,422	330,408	331,925	315,504	350,291	343,525	334,475	303,282	1,186,606		1,340,259		1,331,573		1,324,959	[2]
Selling, general & administrative	88,332	93,615	97,924	95,110	103,265	96,769	102,423	94,091	348,766		374,981		396,548		386,140	[2]
Research, development and engineering	28,841	30,190	29,041	21,706	23,633	23,900	25,774	26,403	91,868		109,778		99,710		100,803	[2]
Operating Earnings from Continuing Operations	49,055	49,894	55,430	28,696	69,942	52,338	26,698	16,771	153,073		183,075		165,749		195,251	[2]
Income Tax Expense	9,705	10,703	13,080	(463)	11,656	7,358	3,004	(161)	16,486		33,025		21,857		24,443	[2]
Earnings from Continuing Operations Attributable to Esterline, Net of Tax	31,533	31,764	34,440	21,128	50,352	36,956	16,270	9,641	95,223		118,865		113,219		126,448	[2]
Net Earnings Attributable to Esterline	$ 30,407	$ 30,949	$ 34,406	$ 15,792	$ 50,579	$ 28,266	$ 14,247	$ 4,861	$ 58,170		$ 111,554		$ 97,953		$ 86,129	[2]
Earnings (Loss) Per Share Attributable to Esterline - Basic:
Continuing operations	$ 1.05	$ 1.07	$ 1.16	$ 0.71	$ 1.71	$ 1.26	$ 0.55	$ 0.32	$ 3.10		$ 4.00		$ 3.84		$ 4.11	[2]
Earnings Per Share	1.01	1.04	1.16	0.53	1.72	0.96	0.48	0.16	1.89		3.75		3.32		2.80	[2]
Earnings (Loss) Per Share Attributable to Esterline - Diluted:
Continuing operations	1.05	1.06	1.15	0.71	1.69	1.24	0.55	0.32	3.05		3.96		3.80		4.05	[2]
Earnings Per Share	$ 1.01	$ 1.03	$ 1.15	$ 0.53	$ 1.70	$ 0.95	$ 0.48	$ 0.16	$ 1.86		$ 3.72		$ 3.29		$ 2.76	[2]
Consolidated Balance Sheet
Accounts receivable, net	$ 430,524				$ 421,511				$ 380,450		$ 430,524		$ 421,511		$ 380,450
Inventories	477,969				447,095				442,315		477,969		447,095		442,315
Prepaid expenses	19,239				18,378				23,156		19,239		18,378		23,156
Deferred income tax benefits	56,793				75,790				27,982		56,793		75,790		27,982
Accounts payable	138,595				126,607				118,734		138,595		126,607		118,734
Accrued liabilities	230,007				235,649				256,147		230,007		235,649		256,147
U.S. and foreign income taxes	582				9,695				1,861		582		9,695		1,861
Other liabilities	18,838				23,026				30,174		18,838		23,026		30,174
Deferred income tax liabilities	43,978				54,325				73,106		43,978		54,325		73,106
Total Shareholders' Equity	1,835,276	$ 1,740,897	$ 1,643,756	$ 1,578,876	1,605,865	$ 1,573,050	$ 1,569,070	$ 1,514,804	1,545,496		1,835,276		1,605,865		1,545,496
As Reported
Consolidated Statement of Operations
Net Sales	531,527	503,753	509,182	457,733	543,752	517,092	490,310	441,477	1,774,449		2,002,195		1,992,631
Cost of Sales	356,663	333,124	333,263	313,686	349,983	343,508	334,137	303,758	1,185,056		1,336,736		1,331,386
Selling, general & administrative	89,082	93,615	97,083	95,633	101,991	96,769	102,423	94,091	346,781		375,413		395,274
Research, development and engineering	27,312	27,866	26,808	21,038	23,179	22,211	24,974	25,575	91,491		103,024		95,939
Operating Earnings from Continuing Operations	58,470	49,148	57,217	29,976	71,156	54,045	27,836	17,122	156,985		194,811		170,159
Income Tax Expense	13,915	10,433	14,160	420	11,177	7,975	3,416	(33)	18,956		38,928		22,535
Earnings from Continuing Operations Attributable to Esterline, Net of Tax	36,738	31,288	35,147	21,525	52,045	38,046	16,996	9,864	96,665		124,698		116,951
Net Earnings Attributable to Esterline	$ 35,612	$ 30,473	$ 35,113	$ 16,189	$ 52,272	$ 29,356	$ 14,973	$ 5,084	$ 59,612		$ 117,387		$ 101,685
Earnings (Loss) Per Share Attributable to Esterline - Basic:
Continuing operations	$ 1.23	$ 1.05	$ 1.18	$ 0.73	$ 1.77	$ 1.30	$ 0.58	$ 0.33	$ 3.15		$ 4.19		$ 3.97
Earnings Per Share	1.19	1.02	1.18	0.55	1.78	1.00	0.51	0.17	1.94		3.94		3.45
Earnings (Loss) Per Share Attributable to Esterline - Diluted:
Continuing operations	1.22	1.04	1.17	0.72	1.75	1.28	0.57	0.33	3.10		4.15		3.93
Earnings Per Share	$ 1.18	$ 1.01	$ 1.17	$ 0.54	$ 1.76	$ 0.99	$ 0.50	$ 0.17	$ 1.91		$ 3.91		$ 3.42
Consolidated Balance Sheet
Accounts receivable, net	$ 437,963				$ 422,073				$ 380,748		$ 437,963		$ 422,073		380,748
Inventories	482,701				450,206				446,768		482,701		450,206		446,768
Prepaid expenses	18,816				17,909				23,008		18,816		17,909		23,008
Deferred income tax benefits	55,355				75,409				28,979		55,355		75,409		28,979
Accounts payable	133,101				121,816				117,976		133,101		121,816		117,976
Accrued liabilities	229,610				238,163				259,734		229,610		238,163		259,734
U.S. and foreign income taxes	6,111				10,932				2,404		6,111		10,932		2,404
Other liabilities	17,658				21,968				29,367		17,658		21,968		29,367
Deferred income tax liabilities	43,978				53,798				73,849		43,978		53,798		73,849
Total Shareholders' Equity	$ 1,847,128	$ 1,747,548	$ 1,650,886	$ 1,585,599	$ 1,611,131	$ 1,577,384	$ 1,572,313	$ 1,517,320	$ 1,547,791		$ 1,847,128		$ 1,611,131		$ 1,547,791

[1] Based on country from which the sale originated and the sale was recorded.

[2] (Recast)